Guideline-Concordant Statin Therapy Use in Secondary Prevention-Reference-Cited by-同舟云学术

Guideline-Concordant Statin Therapy Use in Secondary Prevention

Published:2022-05 Issue:18 Volume:79 Page:1814-1817
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Virani Salim S.,Ballantyne Christie M.,Petersen Laura A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference14 articles.

1. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Grundy;J Am Coll Cardiol,2019

2. High-intensity statin use among patients with atherosclerosis in the U.S.;Nelson;J Am Coll Cardiol,2022

3. Intensity of lipid lowering with statin therapy in patients with cerebrovascular disease versus coronary artery disease: insights from the PALM Registry;Xian;J Am Heart Assoc,2019

4. Utilization rates of SGLT2 inhibitors and GLP-1 receptor agonists and their facility-level variation among patients with atherosclerotic cardiovascular disease and type 2 diabetes: insights from the Department of Veterans Affairs;Mahtta;Diabetes Care,2022

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Highlights of Cardiovascular Disease Prevention Studies Presented at the 2023 American Heart Association Scientific Sessions;Current Atherosclerosis Reports;2024-03-05

2. Comparative effectiveness of moderate-intensity statin with ezetimibe therapy versus high-intensity statin monotherapy in patients with acute coronary syndrome: a nationwide cohort study;Scientific Reports;2024-01-08

3. Does Clinical Decision Support Increase Appropriate Medication Prescribing for Cardiovascular Risk Reduction?;The Journal of the American Board of Family Medicine;2023-09-13

4. Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease;JACC: Heart Failure;2023-08

5. Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease;Circulation;2023-05-02